Home › Alzheimer's Disease › Pennsylvania › Philadelphia
Alzheimer's Disease clinical trials in Philadelphia, PA
15 studies for Alzheimer's Disease are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
RecruitingPhase 2
- Flourish Research - Keystone Clinical Studies- Site Number : 8400003, Plymouth Meeting · 12 mi away
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Pennsylvania Hospital, Philadelphia
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RecruitingPhase 3
- Flourish Research ? Philadelphia, Plymouth Meeting · 12 mi away
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
RecruitingPhase 3Healthy volunteers welcome
- Perelman Center for Advance Medicine, Philadelphia
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
RecruitingPhase 3
- Keystone Clinical Studies, Plymouth Meeting · 12 mi away
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Recruiting
- Hospital of the University of Pennsylvania, Philadelphia
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
RecruitingObservational study
- University of Pennsylvania, Philadelphia
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
RecruitingPhase 2
- Thomas Jefferson University - Vickie & Jack Farber Institute for Neuroscience, Philadelphia
Biofluid Research on Age-Related or Inherited Neurodegeneration
RecruitingObservational studyHealthy volunteers welcome
- University of Pennsylvania, Philadelphia
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
RecruitingPhase 2
- Flourish Research ( Site 1048), Plymouth Meeting · 12 mi away
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Recruiting
- Penn Medicine, Philadelphia
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- Penn Presbyterian Medical Center, Philadelphia
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
RecruitingPhase 2
- Abington Neurological Associates Ltd, Willow Grove · 13 mi away
UPenn Observational Research Repository on Neurodegenerative Disease
RecruitingObservational studyHealthy volunteers welcome
- University of Pennsylvania, Philadelphia
Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
RecruitingEarly phase 1
- University of Pennsylvania, Philadelphia
About Alzheimer's Disease
Alzheimer's disease is a brain disorder that slowly destroys memory and thinking skills. It's the most common cause of dementia among older adults.
More about Alzheimer's Disease on MedlinePlus
Alzheimer's Disease trials in other cities
- Boston, MA26 studies
- Orlando, FL25 studies
- St. Louis, MO22 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Tampa, FL17 studies
- Atlanta, GA16 studies
- The Villages, FL15 studies
- Phoenix, AZ15 studies
- Indianapolis, IN14 studies
- Los Angeles, CA14 studies
- West Palm Beach, FL13 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.